0001209191-17-033761.txt : 20170518
0001209191-17-033761.hdr.sgml : 20170518
20170518203309
ACCESSION NUMBER: 0001209191-17-033761
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170517
FILED AS OF DATE: 20170518
DATE AS OF CHANGE: 20170518
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ADURO BIOTECH, INC.
CENTRAL INDEX KEY: 0001435049
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 740 HEINZ AVENUE
CITY: BERKELEY
STATE: CA
ZIP: 94710
BUSINESS PHONE: 510-848-4400
MAIL ADDRESS:
STREET 1: 740 HEINZ AVENUE
CITY: BERKELEY
STATE: CA
ZIP: 94710
FORMER COMPANY:
FORMER CONFORMED NAME: ADURO BIOTECH
DATE OF NAME CHANGE: 20080514
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brockstedt Dirk G.
CENTRAL INDEX KEY: 0001635616
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37345
FILM NUMBER: 17856247
MAIL ADDRESS:
STREET 1: C/O ADURO BIOTECH, INC.
STREET 2: 740 HEINZ AVENUE
CITY: BERKELEY
STATE: CA
ZIP: 94710
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-05-17
0
0001435049
ADURO BIOTECH, INC.
ADRO
0001635616
Brockstedt Dirk G.
C/O ADURO BIOTECH, INC.
740 HEINZ AVENUE
BERKELEY
CA
94710
0
1
0
0
EVP of Research and Dev.
Common Stock
2017-05-17
4
S
0
1011
9.65
D
49300
D
The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2016.
Includes 1,011 shares acquired by the Reporting Person on May 15, 2017 under the Issuer's 2015 Employee Stock Purchase Plan.
/s/ Jennifer Lew, Attorney-in-Fact
2017-05-18